Christopher J. Burant

Christopher J. Burant

Auto-generated profile, based on publicly available information

Christopher J. Burant

Case Western Reserve University

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
ELElaine Lu
Elaine Lu
NPNataliya Pyatka
Nataliya Pyatka
CBChristopher J Burant
Christopher J Burant
MSMartha M. Sajatovic
Martha M. Sajatovic
Lu E, et al. J Clin Neurol. 2021 Apr;17(2):176-186. https://doi.org/10.3988/jcn.2021.17.2.176

19 October 2016 in Immunity & Ageing
Verified
Journal Article
Open access
PDF file
PEP. Van Epps
P. Van Epps
DOD. Oswald
D. Oswald
PHP. A. Higgins
P. A. Higgins
THT. R. Hornick
T. R. Hornick
HAH. Aung
H. Aung
DCD. H. Canaday
D. H. Canaday
Upregulation of pro-inflammatory cytokines has not only been associated with increased morbidity and mortality in older adults but also has been linked to frailty. In the current study we aimed to compare the relative relationship of age and frailty on inflammation and thrombosis in older veterans. We analyzed 117 subjects (age range 62–95 years; median 81) divided into 3 cohorts: non-frail, pre-frail and frail based on the Fried phenotype of frailty. Serum inflammatory markers were determined using commercially available ELISA kits. Frail and pre-frail (PF) subjects had higher levels than non-frail (NF) subjects of IL-6 (NF vs. PF: p = 0.002; NF vs. F: p < 0.001), TNFR1 (NF vs. F: p = 0.012), TNFRII (NF vs. F: 0.002; NF vs. PF: p = 0.005) and inflammatory index: = 0.333*log(IL-6) + 0.666*log(sTNFR1) (NF vs. F: p = 0.009; NF vs. PF: p < 0.001). Frailty status explained a greater percent of variability in markers of inflammation than age: IL-6 (12 % vs. 0.3 %), TNFR1 (5 % vs. 4 %), TNFR2 (11 % vs. 6 %), inflammatory index (16 % vs. 8 %). Aging was significantly associated with higher fibrinogen (p = 0.04) and D-dimer levels (p = 0.01) but only among NF subjects. In conclusion, these data suggest that among older veterans, frailty status has a stronger association with inflammation and the inflammatory index than age does. Larger studies, in more diverse populations are needed to confirm these findings.

13 April 2016 in The International Journal of Aging and Human Development
Verified
Journal Article
Closed access
CBChristopher J. Burant
Christopher J. Burant
The latent growth curve model (LGCM) is a useful tool in analyzing longitudinal data. It is particularly suitable for gerontological research because the LGCM can track the trajectories and changes of phenomena (e.g., physical health and psychological well-being) over time. Specifically, the LGCM compares lines of change across a set of individuals and determines the overall model's line of change. LGCMs can be used to track either linear or curvilinear trajectories. Since the technique uses structural equation modeling, models are also adjusted for measurement error. This article will present a step-by-step approach to setting up, analyzing, and interpreting an LGCM using post—hospitalization recovery in depressive symptomatology as an example. This article will demonstrate how to test linear, quadratic, and freely estimated lines of change using LGCMs with the purpose of finding the line of trajectory for depressive symptoms that best fits the data.

1 January 2020 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
CBCarol Blixen
Carol Blixen
DODaisy Ogede
Daisy Ogede
FBFarren B. S. Briggs
Farren B. S. Briggs
MAMichelle E. Aebi
Michelle E. Aebi
CBChristopher Burant
Christopher Burant
MSMartha M. Sajatovic
Martha M. Sajatovic
Blixen C, et al. J Clin Neurol. 2020 Jul;16(3):423-432. https://doi.org/10.3988/jcn.2020.16.3.423

1 October 2013 in BMC Immunology
Verified
Journal Article
Open access
PDF file
DCDavid H Canaday
David H Canaday
KPKaren E Parker
Karen E Parker
HAHtin Aung
Htin Aung
HCHui Emily Chen
Hui Emily Chen
DNDariana Nunez-Medina
Dariana Nunez-Medina
CBChristopher J Burant
Christopher J Burant
The immune system consists of multiple preformed and more specific adaptive immune responses, which are all subject to both positive and negative regulation. Programmed cell death protein 1 (PD-1) is a cell surface ligand implicated in the induction of anergy, Inducible T-cell Costimulator (ICOS) plays a stimulatory role in the development of both CD4+ and CD8+ T-cells, Cytotoxic T-Lymphocyte Antigen 4 (CTLA-4) plays a role in inhibitory regulation of T-cell activity, and T cell immunoglobulin and mucin protein 3 (Tim-3) has been described as a negative regulatory molecule in CD4+ helper type 1 cells and CD8+ cytotoxic type 1 cells. Each of these ligands is induced with T-cell activation allowing greater opportunity to have a regulatory role.

1 June 2015 in Journal of Health and Human Services Administration
Verified
Journal Article
Closed access
RHRonald L. Hickman
Ronald L. Hickman
JCJohn M. Clochesy
John M. Clochesy
MPMelissa D. Pinto
Melissa D. Pinto
CBChristopher Burant
Christopher Burant
GPGrant Pignatiello
Grant Pignatiello
Most Americans will acquire a chronic disease during their lifetime. One of the most prevalent chronic diseases that affect Americans is hypertension (HTN). Despite the known comorbidities and increased mortality rate associated with uncontrolled HTN, most community dwelling adults with HTN do not have sufficient blood pressure control. Therefore, the aim of this article is to report the preliminary efficacy of a serious game for health to enhance blood pressure control among community dwelling adults with HTN. A nonprobability sample of 116 community dwelling adults with HTN participated in this nonblinded, randomized controlled trial. Participants were randomly assigned to: (1) an intervention arm that consisted of four exposures to a serious game for health known as eSMART-HD; or (2) an attentional control arm that compromised of four exposures to screen-based HTN education. The primary outcome measure for this trial was blood pressure reduction over a four month observational period. In this study, baseline characteristics and blood pressure measurements were similar between participants in each study arm. There was no significant between-group difference in blood pressure reduction over time. However, there were significant within-group reductions in systolic and diastolic blood pressures across time among favoring participants exposed to eSMART-HD. This study establishes the preliminary efficacy of eSMART-HD that can be easily administered to community dwelling adults and facilitate clinically significant reductions in systolic and diastolic blood pressures. Future studies should assess the influential components of this promising serious game for health (eSMART-HD) combined with medication management in larger and more diverse samples of community dwelling adults with HTN.